Icure Pharmaceutical Incorporation (KOSDAQ:175250)

KOSDAQ:175250 Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 22, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	63,566	81,092	67,826	78,103	79,498	338,828
Market Cap Growth	-21.61%	19.56%	-13.16%	-1.75%	-76.54%	-27.50%
Enterprise Value	81,803	116,156	86,382	142,444	141,972	399,730
Last Close Price	1701.00	2170.00	1815.00	2090.00	2555.00	13038.48

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 22, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	-	-	56.63	-	-	-
Forward PE	-	7.87	7.87	7.87	7.87	7.87
PS Ratio	0.56	0.97	1.34	1.38	1.34	5.27
PB Ratio	2.17	2.95	1.10	1.30	0.87	3.43
P/TBV Ratio	2.32	3.13	1.23	1.53	0.95	3.83

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 22, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
EV/Sales Ratio	0.71	1.39	1.70	2.51	2.39	6.22

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 22, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Debt / Equity Ratio	0.86	1.00	0.66	1.23	0.95	0.75
Net Debt / Equity Ratio	0.58	0.61	0.29	1.09	0.36	0.50
Net Debt / EBITDA Ratio	-3.35	-1.44	-2.51	-3.53	-1.76	-2.23
Net Debt / FCF Ratio	-2.74	-2.13	-0.94	-4.16	-2.15	-1.56
Asset Turnover	1.04	0.74	0.34	0.29	0.27	0.31
Inventory Turnover	7.82	7.24	3.40	4.71	4.72	4.75
Quick Ratio	0.40	0.44	0.53	0.18	0.57	0.66
Current Ratio	0.65	0.62	0.76	0.33	0.73	1.07
Return on Equity (ROE)	-58.78%	-79.17%	5.76%	-42.30%	-44.66%	-35.97%
Return on Assets (ROA)	-5.78%	-10.22%	-6.64%	-8.83%	-7.70%	-9.17%
Return on Invested Capital (ROIC)	-21.46%	-29.60%	-15.56%	-22.02%	-19.80%	-19.54%
Return on Capital Employed (ROCE)	-27.90%	-52.30%	-23.00%	-37.40%	-23.70%	-18.80%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 22, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Earnings Yield	-34.11%	-41.43%	1.77%	-40.04%	-52.54%	-11.26%
FCF Yield	-9.79%	-9.61%	-28.13%	-20.16%	-19.47%	-9.42%
Buyback Yield / Dilution	-0.24%	-0.04%	0.35%	-61.23%	-7.58%	-9.71%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 22, 2026

Data Sources Report a data error